Chizuo Iwai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chizuo Iwai has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Kazunari Fushimi
Department of Orthopaedic Surgery, Gifu University Graduate School of Medicine, Gifu, Japan
8 shared publications - Satoshi Nozawa
Department of Orthopedic Surgery, Gifu University School of Medicine, Gifu, Japan
5 shared publications Katsuji Shimizu
Department of Orthopaedic Surgery, Spine Center, Gifu Municipal Hospital, Gifu, Japan
4 shared publicationsHaruhiko Akiyama
Department of Orthopaedic Surgery, Gifu University Graduate School of Medicine, Gifu, Japan
3 shared publicationsDaisaku Takeuchi
G-SPIRIT Study Group, Chiba, Japan
2 shared publications- Haruhiko Akiyama
Department of Orthopaedic Surgery, Gifu University Graduate School of Medicine, Gifu, Japan
2 shared publications
Latest Publications
- 1 January 2024
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 14 (1)
Surgical Management of Intraosseous Neurofibroma in Cervical Spine
Case: A 30-year-old man had cervical radiculomyelopathy and neck pain caused by a massive intraosseous neurofibroma (IONF) originating from the C6 vertebrae. We performed posterior tumor resection with spinal instrumentation and fusion from C3 to T2 and a follow-up resection procedure of the remaining C6 anterior tumor, sacrificing the affected vertebral artery (VA), which accordingly required bypass surgery at 2 months recovery. Reconstruction using a titanium mesh cage was successfully performed. There were no local recurrences at 2 years postoperatively. Conclusions: Total tumor resection split into 2 stages with sacrifice of the affected VA is a feasible option for treatment of IONF.
- 1 January 2024
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 14 (1)
Surgical Management of Intraosseous Neurofibroma in Cervical Spine
Case: A 30-year-old man had cervical radiculomyelopathy and neck pain caused by a massive intraosseous neurofibroma (IONF) originating from the C6 vertebrae. We performed posterior tumor resection with spinal instrumentation and fusion from C3 to T2 and a follow-up resection procedure of the remaining C6 anterior tumor, sacrificing the affected vertebral artery (VA), which accordingly required bypass surgery at 2 months recovery. Reconstruction using a titanium mesh cage was successfully performed. There were no local recurrences at 2 years postoperatively. Conclusions: Total tumor resection split into 2 stages with sacrifice of the affected VA is a feasible option for treatment of IONF.
- Open Access
- 1 March 2021
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 23, 100940
Surgical management of cervical spinal cord injury in extremely elderly patients, aged 80 or older
- 1 March 2021
- Published by Elsevier in Interdisciplinary Neurosurgery
- Vol. 23, 100940
Open AccessSurgical management of cervical spinal cord injury in extremely elderly patients, aged 80 or older
- 11 September 2020
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 132 (4) , 397-402
Spontaneous morphological remodelling of the O-C1 joint after posterior fusion for occipitocervical dislocation
Traumatic occipitocervical dislocation (OCD) occurs due to fatal high-energy injury. Modern screw-based constructs enable successful reduction and stabilisation. In view of this, there are no previ...
- 11 September 2020
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 132 (4) , 397-402
Spontaneous morphological remodelling of the O-C1 joint after posterior fusion for occipitocervical dislocation
Traumatic occipitocervical dislocation (OCD) occurs due to fatal high-energy injury. Modern screw-based constructs enable successful reduction and stabilisation. In view of this, there are no previ...
- Open Access
- 1 January 2020
- Published by Wiley in Acute Medicine & Surgery
- Vol. 7 (1) , e500
Diffuse midline glioma in the spinal cord with rapid respiratory deterioration
Background: Neurogenic acute respiratory failure is usually caused by either infection or vascular insufficiency. We report the case of a patient who developed acute respiratory failure secondary to a spinal tumor.Case Presentation: A 32‐year‐old man, presenting with numbness and muscle weakness in his legs for 2 weeks, was transferred to our hospital with worsening quadriplegia and development of respiratory symptoms. We carried out emergent spinal decompression and initiated steroid pulse therapy, with no resolution of symptoms; a tumor incision biopsy after contrast cervical magnetic resonance imaging revealed an intraspinal tumor with a pathological diagnosis of World Health Organization grade IV glioma. The patient developed bradycardia, severe sepsis, status epilepticus, and cardiopulmonary arrest due to hypoxemia and was treated with chemoradiotherapy under mechanical ventilation. He was later transferred to another hospital for subacute care.Conclusion: Acute respiratory failure caused by spinal tumors is uncommon. However, acute care practitioners should be mindful of neoplastic lesions as a potential cause.
- 1 January 2020
- Published by Wiley in Acute Medicine & Surgery
- Vol. 7 (1) , e500
Open AccessDiffuse midline glioma in the spinal cord with rapid respiratory deterioration
Background: Neurogenic acute respiratory failure is usually caused by either infection or vascular insufficiency. We report the case of a patient who developed acute respiratory failure secondary to a spinal tumor.Case Presentation: A 32‐year‐old man, presenting with numbness and muscle weakness in his legs for 2 weeks, was transferred to our hospital with worsening quadriplegia and development of respiratory symptoms. We carried out emergent spinal decompression and initiated steroid pulse therapy, with no resolution of symptoms; a tumor incision biopsy after contrast cervical magnetic resonance imaging revealed an intraspinal tumor with a pathological diagnosis of World Health Organization grade IV glioma. The patient developed bradycardia, severe sepsis, status epilepticus, and cardiopulmonary arrest due to hypoxemia and was treated with chemoradiotherapy under mechanical ventilation. He was later transferred to another hospital for subacute care.Conclusion: Acute respiratory failure caused by spinal tumors is uncommon. However, acute care practitioners should be mindful of neoplastic lesions as a potential cause.
- 1 January 2020
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 32 (1) , 61-62
Repetitive distortion of the spinal cord owing to a pulsating arachnoid cyst: case illustration
- 1 January 2020
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 32 (1) , 61-62
Repetitive distortion of the spinal cord owing to a pulsating arachnoid cyst: case illustration
- 11 June 2018
- Published by Springer Nature in European Spine Journal
- Vol. 27 (S3) , 549-554
Bilateral vocal cord palsy after a posterior cervical laminoplasty
To report a patient with bilateral vocal cord palsy following cervical laminoplasty, who survived following a tracheotomy and intensive respiratory care.
- 11 June 2018
- Published by Springer Nature in European Spine Journal
- Vol. 27 (S3) , 549-554
Bilateral vocal cord palsy after a posterior cervical laminoplasty
To report a patient with bilateral vocal cord palsy following cervical laminoplasty, who survived following a tracheotomy and intensive respiratory care.
- Open Access
Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury
Introduction: Granulocyte colony-stimulating factor (G-CSF) is generally used for neutropaenia. Previous experimental studies revealed that G-CSF promoted neurological recovery after spinal cord injury (SCI). Next, we moved to early phase of clinical trials. In a phase I/IIa trial, no adverse events were observed. Next, we conducted a non-randomised, non-blinded, comparative trial, which suggested the efficacy of G-CSF for promoting neurological recovery. Based on those results, we are now performing a phase III trial. Methods and analysis: The objective of this study is to evaluate the efficacy of G-CSF for acute SCI. The study design is a prospective, multicentre, randomised, double-blinded, placebo-controlled comparative study. The current trial includes cervical SCI (severity of American Spinal Injury Association (ASIA) Impairment Scale B/C) within 48 hours after injury. Patients are randomly assigned to G-CSF and placebo groups. The G-CSF group is administered 400 µg/m 2 /day×5 days of G-CSF in normal saline via intravenous infusion for 5 consecutive days. The placebo group is similarly administered a placebo. Our primary endpoint is changes in ASIA motor scores from baseline to 3 months. Each group includes 44 patients (88 total patients). Ethics and dissemination: The study will be conducted according to the principles of the World Medical Association Declaration of Helsinki and in accordance with the Japanese Medical Research Involving Human Subjects Act and other guidelines, regulations and Acts. Results of the clinical study will be submitted to the head of the respective clinical study site as a report after conclusion of the clinical study by the sponsor-investigator. Even if the results are not favourable despite conducting the clinical study properly, the data will be published as a paper. Trial registration number: UMIN000018752.
Open AccessStudy protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury
Introduction: Granulocyte colony-stimulating factor (G-CSF) is generally used for neutropaenia. Previous experimental studies revealed that G-CSF promoted neurological recovery after spinal cord injury (SCI). Next, we moved to early phase of clinical trials. In a phase I/IIa trial, no adverse events were observed. Next, we conducted a non-randomised, non-blinded, comparative trial, which suggested the efficacy of G-CSF for promoting neurological recovery. Based on those results, we are now performing a phase III trial. Methods and analysis: The objective of this study is to evaluate the efficacy of G-CSF for acute SCI. The study design is a prospective, multicentre, randomised, double-blinded, placebo-controlled comparative study. The current trial includes cervical SCI (severity of American Spinal Injury Association (ASIA) Impairment Scale B/C) within 48 hours after injury. Patients are randomly assigned to G-CSF and placebo groups. The G-CSF group is administered 400 µg/m 2 /day×5 days of G-CSF in normal saline via intravenous infusion for 5 consecutive days. The placebo group is similarly administered a placebo. Our primary endpoint is changes in ASIA motor scores from baseline to 3 months. Each group includes 44 patients (88 total patients). Ethics and dissemination: The study will be conducted according to the principles of the World Medical Association Declaration of Helsinki and in accordance with the Japanese Medical Research Involving Human Subjects Act and other guidelines, regulations and Acts. Results of the clinical study will be submitted to the head of the respective clinical study site as a report after conclusion of the clinical study by the sponsor-investigator. Even if the results are not favourable despite conducting the clinical study properly, the data will be published as a paper. Trial registration number: UMIN000018752.
- 1 January 2013
- Published by Wolters Kluwer Health in Spine
- Vol. 38 (1) , 44-50
Clinical Outcomes of Combined Anterior and Posterior Spinal Fusion for Dystrophic Thoracolumbar Spinal Deformities of Neurofibromatosis-1
Study Design. Retrospective study. Objective. To analyze the clinical outcomes of anterior and posterior spinal fusion (APSF) using a fibular strut autograft (FSAG) and to investigate the morphological changes in the reconstructed spinal column of dystrophic deformities in neurofibromatosis (NF)-1. Summary of Background Data. APSF is desirable for dystrophic deformities in NF-1 with more than 50° of dystrophic kyphosis. There are few reports regarding the clinical outcomes of APSF in which the morphological changes over time of the anterior strut graft have been investigated. Methods. The clinical and radiographic outcomes of APSF with FSAG were investigated in 10 consecutive patients with dystrophic deformity in NF-1. For qualitative and quantitative analyses, the chronological changes in the FSAG configuration, length, and diameter were evaluated. Results. The mean follow-up period was 9 years, 9 months (range, 1–30 years). Graft bone erosion and postoperative curve progression were not observed in any patient. In quantitative analyses of the anterior strut, the mean ratio of the latest and immediately postoperative FSAG lengths was 0.98 (0.93–1.09). The mean central/peripheral ratios of the FSAG diameter (central portion/[upper end + lower end]/2) were 1.02 (0.92–1.10) immediately after surgery, and 1.01 (0.92–1.07) at the latest follow-up, with no significant change between these 2 time points (P = 0.937). The mean preoperative cross-sectional area of the apical vertebral body and its mean virtual cross-sectional area at the final follow-up were 3.80 (1.83–5.43) and 4.87 (2.46–7.00) cm2, respectively, with a significant difference between these 2 parameters (P = 0.0078). The mean final/preoperative ratio was 1.31 (1.10–1.43). Conclusion. APSF with FSAG for dystrophic deformity in NF-1 successfully reconstructed a reliable spinal column with a rich bone stock. The FSAG and surrounding vertebral bodies were free from postoperative erosion due to dystrophic changes and maintained their stability for a long time.
- 1 January 2013
- Published by Wolters Kluwer Health in Spine
- Vol. 38 (1) , 44-50
Clinical Outcomes of Combined Anterior and Posterior Spinal Fusion for Dystrophic Thoracolumbar Spinal Deformities of Neurofibromatosis-1
Study Design. Retrospective study. Objective. To analyze the clinical outcomes of anterior and posterior spinal fusion (APSF) using a fibular strut autograft (FSAG) and to investigate the morphological changes in the reconstructed spinal column of dystrophic deformities in neurofibromatosis (NF)-1. Summary of Background Data. APSF is desirable for dystrophic deformities in NF-1 with more than 50° of dystrophic kyphosis. There are few reports regarding the clinical outcomes of APSF in which the morphological changes over time of the anterior strut graft have been investigated. Methods. The clinical and radiographic outcomes of APSF with FSAG were investigated in 10 consecutive patients with dystrophic deformity in NF-1. For qualitative and quantitative analyses, the chronological changes in the FSAG configuration, length, and diameter were evaluated. Results. The mean follow-up period was 9 years, 9 months (range, 1–30 years). Graft bone erosion and postoperative curve progression were not observed in any patient. In quantitative analyses of the anterior strut, the mean ratio of the latest and immediately postoperative FSAG lengths was 0.98 (0.93–1.09). The mean central/peripheral ratios of the FSAG diameter (central portion/[upper end + lower end]/2) were 1.02 (0.92–1.10) immediately after surgery, and 1.01 (0.92–1.07) at the latest follow-up, with no significant change between these 2 time points (P = 0.937). The mean preoperative cross-sectional area of the apical vertebral body and its mean virtual cross-sectional area at the final follow-up were 3.80 (1.83–5.43) and 4.87 (2.46–7.00) cm2, respectively, with a significant difference between these 2 parameters (P = 0.0078). The mean final/preoperative ratio was 1.31 (1.10–1.43). Conclusion. APSF with FSAG for dystrophic deformity in NF-1 successfully reconstructed a reliable spinal column with a rich bone stock. The FSAG and surrounding vertebral bodies were free from postoperative erosion due to dystrophic changes and maintained their stability for a long time.
- 30 December 2010
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 131 (9) , 1177-1185
Anterior cervical multilevel decompression and fusion using fibular strut as revision surgery for failed cervical laminoplasty
Retrospective analyses of six cases. To describe six patients with previous failed laminoplasty who were subsequently managed by anterior cervical decompression and fusion (ACDF) using fibular strut as revision surgeries. While several complications and unsatisfactory results of cervical laminoplasty have been reported, there is no general consensus on how to best surgically treat these pathological conditions. Six patients, who had been treated by laminoplasty for cervical spondylotic myelopathy (n = 2) or ossification of posterior longitudinal ligament (OPLL, n = 4) and had unfavorable outcomes, underwent ACDF using autogenous fibular strut grafts. The pathological factors associated with the poor outcomes were intraforaminal spur, slip, spondylotic change, disc herniation, and increase of OPLL in size. Clinical outcomes were assessed by evaluating the modified Japanese Orthopedic Association score (JOA score) of cervical myelopathy, severity of radicular pains, axial pains, and perioperative complications. In addition, C2–7 angle and the presence of bony union were analyzed. The revision ACDF significantly increased the mean ± SD. JOA score, from 10.3 ± 3.9 to 13.5 ± 2.7 points (p = 0.028), with a recovery rate of 47.1 ± 26.7%. Radicular pain and axial pain also improved. C2–7 angle was not changed significantly. Solid fusion was achieved in all patients at 12.2 ± 4.2 months after revision surgery. ACDF with fibular strut graft was effective as a revision procedure for failed laminoplasty.
- 30 December 2010
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 131 (9) , 1177-1185
Anterior cervical multilevel decompression and fusion using fibular strut as revision surgery for failed cervical laminoplasty
Retrospective analyses of six cases. To describe six patients with previous failed laminoplasty who were subsequently managed by anterior cervical decompression and fusion (ACDF) using fibular strut as revision surgeries. While several complications and unsatisfactory results of cervical laminoplasty have been reported, there is no general consensus on how to best surgically treat these pathological conditions. Six patients, who had been treated by laminoplasty for cervical spondylotic myelopathy (n = 2) or ossification of posterior longitudinal ligament (OPLL, n = 4) and had unfavorable outcomes, underwent ACDF using autogenous fibular strut grafts. The pathological factors associated with the poor outcomes were intraforaminal spur, slip, spondylotic change, disc herniation, and increase of OPLL in size. Clinical outcomes were assessed by evaluating the modified Japanese Orthopedic Association score (JOA score) of cervical myelopathy, severity of radicular pains, axial pains, and perioperative complications. In addition, C2–7 angle and the presence of bony union were analyzed. The revision ACDF significantly increased the mean ± SD. JOA score, from 10.3 ± 3.9 to 13.5 ± 2.7 points (p = 0.028), with a recovery rate of 47.1 ± 26.7%. Radicular pain and axial pain also improved. C2–7 angle was not changed significantly. Solid fusion was achieved in all patients at 12.2 ± 4.2 months after revision surgery. ACDF with fibular strut graft was effective as a revision procedure for failed laminoplasty.
- 1 April 2010
- Published by Wolters Kluwer Health in Journal of Spinal Disorders & Techniques
- Vol. 23 (2) , 133-138
Surgical Outcome of 2-stage (Posterior and Anterior) Surgical Treatment Using Spinal Instrumentation for Tuberculous Spondylitis
A prospective study on the clinical outcomes in patients with tuberculous spondylitis treated by a 2-stage operation (posterior and anterior) using posterior spinal instrumentation. To evaluate the clinical outcomes of the 2-stage surgical treatment (first stage: placement of posterior instrumentation and second stage: anterior debridement and bone grafting) for tuberculous spondylitis. There have been few reports describing the effects of 2-stage surgical treatment for tuberculous spondylitis. Ten patients (5 men and 5 women) with tuberculous spondylitis were treated by 2-stage operations. Age at the initial operation was 64.6±14.8 years (average±SD) (range: 47 to 83 y). The clinical outcomes were evaluated before and after the surgery in terms of hematologic examination, pain level, and neurologic status. Bone fusion and changes in sagittal alignment were examined radiographically. All patients showed suppression of infection, bony fusion, relief of pain, and recovery of neurologic function. No significant changes were observed in kyphosis angle at the final follow-up. There were no incidences of severe complications or recurrence. Our results showed that posterior and anterior 2-stage surgical treatment for tuberculous spondylitis is a viable surgical option for cases in which conservative treatment has failed. However, the changes in sagittal alignment showed that this strategy provides limited kyphosis correction.
- 1 April 2010
- Published by Wolters Kluwer Health in Journal of Spinal Disorders & Techniques
- Vol. 23 (2) , 133-138
Surgical Outcome of 2-stage (Posterior and Anterior) Surgical Treatment Using Spinal Instrumentation for Tuberculous Spondylitis
A prospective study on the clinical outcomes in patients with tuberculous spondylitis treated by a 2-stage operation (posterior and anterior) using posterior spinal instrumentation. To evaluate the clinical outcomes of the 2-stage surgical treatment (first stage: placement of posterior instrumentation and second stage: anterior debridement and bone grafting) for tuberculous spondylitis. There have been few reports describing the effects of 2-stage surgical treatment for tuberculous spondylitis. Ten patients (5 men and 5 women) with tuberculous spondylitis were treated by 2-stage operations. Age at the initial operation was 64.6±14.8 years (average±SD) (range: 47 to 83 y). The clinical outcomes were evaluated before and after the surgery in terms of hematologic examination, pain level, and neurologic status. Bone fusion and changes in sagittal alignment were examined radiographically. All patients showed suppression of infection, bony fusion, relief of pain, and recovery of neurologic function. No significant changes were observed in kyphosis angle at the final follow-up. There were no incidences of severe complications or recurrence. Our results showed that posterior and anterior 2-stage surgical treatment for tuberculous spondylitis is a viable surgical option for cases in which conservative treatment has failed. However, the changes in sagittal alignment showed that this strategy provides limited kyphosis correction.